drugset / Trial / NCT06249152
Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Qlaris Phase 2 clinical study investigating the safety, tolerability, and ocular hypotensive efficacy of QLS-111 in combination with latanoprost in open-angle glaucoma (OAG) and/or ocular hypertension (OHT) patients.
Timeline
- Start
- 2024-04-21
- Primary completion
- 2024-12-20
- Completion
- 2024-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QLS-111 | Unknown | 0.015 % | Other |
| Subject | QLS-111 | Unknown | 0.03 % | Other |
| Subject | QLS-111 | Unknown | 0.075 % | Other |